Alzamend Neuro, Inc.ALZNEarnings & Financial Report
Nasdaq
NextMar 31, 2026
ALZN Q4 2023 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-3.3M
Net Profit
$-3.3M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$1.19
Alzamend Neuro, Inc. Q4 2023 Financial Summary
Alzamend Neuro, Inc. reported revenue of $0 for Q4 2023, with a net profit of $-3.3M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-3.3M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2023 |
Alzamend Neuro, Inc. Annual Revenue by Year
Alzamend Neuro, Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $16.8M | $14.5M | $12.4M | $14.5M | $12.2M | $10.4M | $8.5M | $5.9M |
| Liabilities | N/A | N/A | N/A | $1.2M | $1.0M | $1.6M | $2.6M | $2.9M |
| Equity | $15.3M | $13.0M | $12.0M | $13.4M | $11.2M | $8.8M | $5.9M | $3.0M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.2M | $-2.0M | $-1.8M | $-1.6M | $-2.5M | $-2.3M | $-1.8M | $-2.2M |